Skip to main contentAI and Advanced
/
PGHL · NSEBSE SENSEX74,336.45+0.45%BSE |
NIFTY 5023,217.6+0.43%NSE |
NIFTY BANK56,292.45+0.89%NSE |
NIFTY IT29,087.65-1.58%NSE |
NIFTY AUTO26,893.65+0.51%NSE |
NIFTY FMCG45,559+1.63%NSE |
NIFTY PHARMA26,146.2-0.16%NSE |
NIFTY 50022,532+0.24%NSE |
PG
NSE · Equity shares · Biotechnology & Drugs32.50 · 0.60%
Procter & Gamble Health PGHL
NSE:INR 5,440.5
BSE:INR 5,472.3
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for PGHL
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 5,408
Day rangeINR 5,365 — INR 5,568
52-week rangeINR 4,699.7 — INR 6,975
Volume13,561
Market cap10,123.57
P/E24.37
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)1,407.97
Net Income (INR Cr)326.91
P/E Ratio24.37
Book Value315.72
EPS196.94
Price/BV17.23Computed
Research path: Interpret Procter & Gamble Health's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
PGHLProcter & Gamble Health1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 841.35 | 794.2 | 794.36 |
| Cash Equivalents | 177.24 | 89.81 | 149.77 |
| Other Liabilities Total | 56.15 | 37.12 | 30.33 |
| Common Stock Total | 16.6 | 16.6 | 16.6 |
| Other Current Assets Total | 59.85 | 7.57 | 14.86 |
| Total Assets | 841.35 | 794.2 | 794.36 |
| Current Portof LT Debt/Capital Leases | 3.57 | 2.81 | 2.68 |
| Total Equity | 524.55 | 536.96 | 538.24 |
| Long Term Investments | 2.51 | 4.37 | 1.9 |
| Retained Earnings(Accumulated Deficit) | 507.95 | 509.23 | 510.51 |
| Total Common Shares Outstanding | 1.66 | 1.66 | 1.66 |
| Tangible Book Valueper Share Common Eq | 315.72 | 323.05 | 323.67 |
| Total Liabilities | 316.8 | 257.24 | 256.12 |
| Total Debt | 9.29 | 7.62 | 9.56 |
| Short Term Investments | 16.17 | Not available | 13.37 |
| Cashand Short Term Investments | 193.41 | 182.08 | 251.87 |
| Total Receivables Net | 166.35 | 222.11 | 145.08 |
| Accounts Receivable-Trade Net | 164.26 | 145.52 | 85.33 |
| Property/Plant/Equipment Total-Net | 112.83 | 121.99 | 131.53 |
| Total Current Liabilities | 254.93 | 215.31 | 218.91 |
| Total Inventory | 136.65 | 110.12 | 110.61 |
| Accounts Payable | 192.17 | 171.6 | 167 |
| Other Currentliabilities Total | 59.19 | 26.16 | 23.29 |
| Total Long Term Debt | 5.72 | 4.81 | 6.88 |
| Intangibles Net | 0.47 | 0.71 | 0.96 |
| Other Long Term Assets Total | 78.56 | 39.85 | 39.93 |
| Note Receivable-Long Term | 90.72 | 100.89 | 95.82 |
| Total Current Assets | 556.26 | 526.39 | 524.22 |
| Capital Lease Obligations | 5.72 | 4.81 | 6.88 |
| Accumulated Depreciation Total | Not available | -109.4 | -96.18 |
| Accrued Expenses | Not available | 14.74 | 25.94 |
| Prepaid Expenses | Not available | 4.51 | 1.8 |
| Additional Paid-In Capital | Not available | 11.13 | 11.13 |
| Cash | Not available | 92.27 | 88.73 |
| Property/Plant/Equipment Total-Gross | Not available | 220.43 | 221.82 |
| Notes Payable/Short Term Debt | Not available | 0 | 0 |
Fundamentals
Valuation and ratios
Margins
Operating Margin 12m30.76
Net Profit Margin 12m23.22
Yield
Dividend Yield %2.4
Valuation
Price to Sale Ratio7.19
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk29.43
Analyst consensus
ConsensusBuy
Consensus score2.00
Analyst opinions1
Strong Sell count0
Sell count0
Hold count0
Buy count1
Strong Buy count0
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | INR 1,944 | 4.66 L | 38.4 | — |
| Divi's Laboratories | INR 8,291.55 | 2.20 L | 73.32 | — |
| Torrent Pharmaceuticals | INR 4,965 | 1.89 L | 72.73 | — |
| Cipla | INR 1,475 | 1.19 L | 27.57 | — |
| Zydus Lifesciences | INR 1,106.25 | 1.10 L | 21.19 | — |
Shareholding
Ownership
- Promoter
- 51.82%
- FII
- 6.33%
- MF
- 9.05%
- Other
- 32.80%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Westpac Banking Corp Sells 13,443 Shares of Procter & Gamble Company (The) $PG - MarketBeatMarket news · 22 Jul 2026, 4:19 pm
Westpac Banking Corp Sells 13,443 Shares of Procter & Gamble Company (The) $PG MarketBeat
Procter & Gamble Company (The) $PG Shares Sold by Rit Capital Partners PLC - MarketBeatMarket news · 22 Jul 2026, 3:32 pm
Procter & Gamble Company (The) $PG Shares Sold by Rit Capital Partners PLC MarketBeat
PNC Financial Services Group Inc. Lowers Stock Holdings in Procter & Gamble Company (The) $PG - MarketBeatMarket news · 22 Jul 2026, 3:32 pm
PNC Financial Services Group Inc. Lowers Stock Holdings in Procter & Gamble Company (The) $PG MarketBeat
Oslo Pensjonsforsikring AS Makes New Investment in Procter & Gamble Company (The) $PG - MarketBeatMarket news · 22 Jul 2026, 3:19 pm
Oslo Pensjonsforsikring AS Makes New Investment in Procter & Gamble Company (The) $PG MarketBeat
Danica Pension Livsforsikringsaktieselskab Invests $27.90 Million in Procter & Gamble Company (The) $PG - MarketBeatMarket news · 22 Jul 2026, 2:31 pm
Danica Pension Livsforsikringsaktieselskab Invests $27.90 Million in Procter & Gamble Company (The) $PG MarketBeat
CI Investments Inc. Has $40.67 Million Stock Holdings in Procter & Gamble Company (The) $PG - MarketBeatMarket news · 22 Jul 2026, 2:14 pm
CI Investments Inc. Has $40.67 Million Stock Holdings in Procter & Gamble Company (The) $PG MarketBeat
Corporate actions
Events
- dividendRs.45.0000 per share(450%)Final Dividend (RD & XD dates revised)
- board MeetingsQuarterly Results
- board MeetingsAudited Results & Final Dividend
- dividendRs.110.0000 per share(1100%)Interim Dividend
- dividendRs.50.0000 per share(500%)Special Dividend
- board MeetingsQuarterly Results & Interim Dividend
- board MeetingsQuarterly Results & Interim Dividend
- annual General MeetingAGM
Rusaka Markets Community
Discussion and sentiment for Procter & Gamble Health
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
Company facts
- Industry
- Biotechnology & Drugs
- Sector
- Biotechnology & Drugs
- NSE Code
- PGHL
- BSE Code
- 500126
Questions
Stock FAQ
What is the symbol and ISIN of Procter & Gamble Health?
Procter & Gamble Health has the symbol PGHL and ISIN - INE199A01012.
What is the current price of Procter & Gamble Health?
Procter & Gamble Health is currently trading at INR 5,440.50.
What are the year high and year low of Procter & Gamble Health?
Procter & Gamble Health has a year high of INR 6,975.00 and a year low of INR 4,699.70.
What is the market capitalization of Procter & Gamble Health?
Procter & Gamble Health has a market capitalization of INR 10,123.57 crore.
What is the P/E ratio of Procter & Gamble Health?
Procter & Gamble Health has a P/E ratio of 24.37.
What is the dividend yield of Procter & Gamble Health?
Procter & Gamble Health has a dividend yield of 2.40%.
How is the financial performance of Procter & Gamble Health based on revenue, net income, and EPS?
Procter & Gamble Health has revenue of INR 1,407.97 crore, net income of INR 326.91 crore, and EPS of INR 196.94.
What is the book value of Procter & Gamble Health?
Procter & Gamble Health has a book value of INR 315.72.
What is the debt-to-equity ratio of Procter & Gamble Health?
Procter & Gamble Health has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Procter & Gamble Health?
Procter & Gamble Health has a price-to-book ratio of 17.23 and a price-to-sales ratio of 7.19.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.